Reducing Skin Surface pH During Skin Occlusion: Changes to Skin Microbiome and Skin Parameters

NCT ID: NCT06363786

Last Updated: 2025-03-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-15

Study Completion Date

2024-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main aim of this exploratory research study is to investigate how exposure to a material with low pH affects the skin microbiome and skin parameters. This investigation involves an experimental setup in which application of test patches with lowered pH levels or control patches without lowered pH are used. The test patches are applied on healthy adult volunteers. About 20 subjects are planned for the study. The skin microbiome preservation and diversity will be addressed employing Molecular Sequencing and quantitative polymerase chain reaction (qPCR). In addition, skin pH, composition and hydration will be measured with various methods, e.g., AquaFlux, Moisture Meter, TEWL and Confocal Raman spectroscopy. The study will span three consecutive days in total. Each participant will be provided with four patches on each forearm: two patches will be applied to each dorsal forearm and two on each volar forearm. The first day will be for study inclusion and application of patches. In day two the patches will be changed and on day three measurements for pH, TEWL, skin hydration, Raman and tape stripping will be conducted and sampling for Molecular Sequencing and qPCR measurements will be done. There is no formal hypothesis in the study but our idea is that utilizing patches with a lower pH could maintain the diversity and richness of the natural skin microbiome while retaining and even enhancing key skin barrier parameters. A descriptive analysis will be conducted for all measurements with appropriate statistical tests on 5% level for variables. In addition to descriptive data analysis statistics, Clinical Microbiomics and Bio-Me Microbiome Profiling will employ various statistical methods, such as paired Mann-Whitney U tests. The Benjamini-Hochberg (BH) method to control the false discovery rate (FDR) will be employed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Incontinence-associated Dermatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Healthy volunteers get patches carrying a low pH or control formula applied to the forearms. The patches are carried over two days and the skin parameters and skin microbiome is measured on day 3.
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Test patches

Application of test patches. Each subject wear both low pH formula patches (intervention) and control patches without formula.

Group Type EXPERIMENTAL

Test patches

Intervention Type OTHER

Patches (incontinence product cut outs) with a low pH formula or control patches without formula.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Test patches

Patches (incontinence product cut outs) with a low pH formula or control patches without formula.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Signed Informed Consent Form
2. Male and female ≥18 and ≤80 years.
3. Willingness and ability to comply with study procedures, visit schedules, and requirements.
4. Intact skin on the forearms without any signs of irritation.
5. Agree not to shower or use cosmetic products on the arms the day before visit 1 and during the study period.
6. Agree not to engage in intense physical activity throughout the study period.

Exclusion Criteria

1. Have any known allergies or intolerances to one or several components of the absorbing incontinence/menstrual products.
2. Have any known allergies or intolerances to one or several ingredients in cosmetic products.
3. Have an ongoing skin irritation/infection on the forearms.
4. Have any skin conditions such as psoriasis and eczema.
5. Have any tattoos on the forearms.
6. Suffer from excessive sweating, hyperhidrosis.
7. Have immunodeficiency or any other condition that makes participation in the clinical investigation inappropriate, as judged by investigator.
8. Have an alcohol and/or drug dependency.
9. Have had active sunbathing on arms latest 2 weeks prior to study.
10. Have used tanning or bleaching products on arms at least 1 month before the study starts.
11. Have performed hair removal on the arms 1 month prior to the study.
12. Are pregnant or nursing.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Essity Hygiene and Health AB

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ulrika Husmark, PhD

Role: PRINCIPAL_INVESTIGATOR

Essity Hygiene and Health AB

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Essity Study Site

Gothenburg, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GOOSEBERRY

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Developing Of A New Incontinence Care Product
NCT02991833 COMPLETED EARLY_PHASE1